ViiV Healthcare Australia through its Positive Action Community Grants is looking to fund community-based projects that reach those most affected by, or at risk of HIV, particularly in marginalised, hard to reach or vulnerable populations. The funding supports initiatives that are innovative, sustainable and produce tangible results for PWHIV.
Partnerships and collaborations are encouraged and ViiV will prioritise submissions that allow for implementation replication on either a national level or in other jurisdictions.
About the funding initiative
ViiV Healthcare is a specialist pharmaceutical company 100% focused on combating, preventing and ultimately curing HIV and AIDS. ViiV’s collective determination is to make sure no one at risk of or living with HIV is left behind.
Its vision is to end the HIV/AIDS epidemic, by developing innovative medicines, delivering and supporting more effective solutions in care and being partners – to people with HIV (PWHIV), their carers and communities.
One way in which ViiV Healthcare supports the community response is via the Australian Positive Action Community Grants program. This program is aligned with the current priorities of the Eighth National HIV Strategy and contributes to the holistic response of UNAIDS 90–90–90 goals and “the fourth 90”.
Positive Action was created in 1992 by the pharmaceutical company GSK, who still holds an interest in ViiV. It was the first pharmaceutical company program to support communities affected by HIV and AIDS.
Applications open Monday, 3rd October 2022 (9am)
Applications close Monday, 31 October 2022 (5pm)